Ascentage Pharma Group International

Insider filings show Ascentage Pharma’s owner Ye Changqing keeps stable, long‑term stakes while market buzz hints at upcoming moves – a sign of confidence for investors.

Insider trades show confidence in Ascentage’s pipeline, as CEO Yang Dajun keeps his stake steady while execs trade modestly ahead of AACR pre‑clinical abstracts, hinting at possible upside.